Founded in 2018 as an emerging company from the prestigious Bascom Palmer Eye Institute, Ocubio emerged with a singular vision: to harness the regenerative potential of personalized therapies for ocular health. Armed with an exclusive license, Ocubio embarked on a journey to develop and commercialize innovative therapies, leveraging a proprietary manufacturing protocol meticulously crafted to ensure consistency, high quality, and remarkable ocular regenerative properties.
In addition to its foundational roots, Ocubio’s innovation trajectory was further propelled by prestigious STTR awards from the US Department of Defense. Securing both Phase 1 and Phase 2 grants, Ocubio embarked on a groundbreaking endeavor to develop the first biologic pharmaceutical eye solution for patients with dry eye disease. These awards served as a testament to Ocubio’s exceptional capabilities and the transformative potential of its research in addressing critical ocular health challenges.
We aspire to create a future where every person has access to personalized ocular solutions tailored to their unique needs, enhancing their vision and quality of life.
Ocubio’s mission is to transform the landscape of eye care through pioneering and personalized ocular medicine, revolutionizing how individuals experience and perceive eye health.
Chief Vision Officer
Chief Executive Officer
Chief Scientific Officer
Chief Financial Officer
Are you passionate about revolutionizing eye care and shaping the future of ocular health? Join Ocubio, where innovation meets purpose, and become part of a dynamic team committed to pushing the boundaries of possibility. Join us in our mission to transform lives through cutting-edge ocular therapies and make a meaningful impact in the world of eye care.